Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.

Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.

Abstract: Disclosed herein are compositions comprising brimonidine and timolol. Methods and medicaments related thereto are also disclosed.

Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.

Abstract: An activated carbon-metal oxide matrix is disclosed. The activated carbon-metal oxide matrix may be obtained by a method including the steps of: preoxidizing a carbon material, grinding the preoxidized carbon material; mixing the ground preoxidized material with a metal oxide to form a carbon mixture; extruding the carbon mixture; carbonizing and activating the extrudate. The activated carbon-metal oxide matrix may be used to remove odorous compounds, acidic gases, and volatile organic compounds from a gas.

Abstract: A fuel cell system includes a de-sulfurization tank, a reformer, a pressure monitoring device and a fuel cell stack. The de-sulfurization tank includes an agent that is adapted to remove sulfur compounds and is capable of undergoing a conditioning cycle. The tank includes an inlet to receive a first hydrocarbon flow and an outlet to provide a second hydrocarbon flow. The reformer is adapted to convert the second hydrocarbon flow into a reformate flow, which is received by the fuel cell stack. The pressure monitoring device monitors a pressure of the second hydrocarbon flow, a circuit of the fuel cell system is coupled to the pressure monitoring device to determine whether the conditioning of the tank is complete based on the pressure.

Abstract: A liquid comprising a therapeutically effective concentration of a cyclosporin and a vitamin E tocopherol polyethylene glycol succinate, wherein said liquid is an emulsion. is disclosed herein. Methods of treating diseases or conditions using said compositions, and medicaments related thereto, are also disclosed herein.

Abstract: A device for controlling odor from a toilet bowl has a housing primarily formed by a top member, a bottom member and a canister holding section for attaching to the bottom member. The canister holding section holds a canister having a nozzle for providing an odor treating spray from the canister. The housing also has two plates depending downwardly from the bottom member and which form an inverted U-shape for mounting the device on a rim of the toilet bowl. Between the top member and bottom member is a biasing device such as springs for biasing a seat of the toilet bowl in an upward direction when the seat is empty, and for allowing the seat to move in a downward direction in response to someone sitting on the seat. The downward motion of the seat moves the top member down, thereby actuating a nozzle on the canister, spraying a metered amount of spray into the toilet bowl.

Abstract: Multi-purpose solutions for contact lens care provide substantial lens wearer/user comfort and/or acceptability. Such solutions include an aqueous liquid medium; an antimicrobial component, preferably a biguanide polymer present in an amount of less than about 5 ppm; propylene glycol or glycerin in an amount sufficient to increase antimicrobial activity; a surfactant component, preferably a poly(oxyethylene)-poly(oxypropylene) block copolymer surfactant, in an effective amount; a phosphate buffer component in an effective amount; a viscosity inducing component, preferably selected from cellulosic derivatives, in an effective amount; and a tonicity component in an effective amount. Such solutions have substantial performance, comfort and acceptability benefits, which, ultimately, lead to ocular health advantages and avoidance of problems caused by contact lens wear.

Abstract: Disclosed herein are dosage forms comprising an alpha-2-adrenergic agonist and a trefoil factor family peptide. Related to these dosage forms are methods of treating glaucoma or reducing intraocular pressure and methods of treating gastrointestinal disorders.

Abstract: A composition is described herein comprising cyclosporin A, polysorbate 80, a polyoxyethylene stearate, and an oil; wherein the composition is an emulsion which is ophthalmically acceptable. Methods of treating diseases or conditions using said compositions, and medicaments related thereto, are also disclosed herein.

Abstract: A computer-implemented method and computer program product for providing data that includes location-based access control information concerning a data relay device located within a network infrastructure. The data relay device is loaded with one or more features, such that the one or more features loaded are dependent, at least in part, upon the location-based access control information.

Abstract: Disclosed are methods of preventing or treating a disease or adverse condition affecting the gastrointestinal tract of a mammal which comprise orally administering to a mammal a therapeutically effective amount of a prodrug of a proton pump inhibitor and an effective amount of a trefoil family factor peptide, mucoadhesive agent, or a combination thereof. Also disclosed are compositions which are suitable for use in a pharmaceutical dosage form. These compositions comprise a prodrug of a proton pump inhibitor, and also comprise a trefoil family factor peptide, a mucoadhesive component, or a combination thereof.

Abstract: The invention relates to novel 5-Ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.

Abstract: A feature set module for programming features of a vehicle control system is disclosed. The feature set module is designed to be easily attached to or detached from an interface module of a control system. The feature set module may include a latching mechanism to secure the feature set module to the interface module. Additionally, the feature set module has terminals that communicate with terminals of the interface module.

Abstract: An abdominal muscle and spine exercising device includes a frame having a top and a bottom surface with first and second bladders disposed on the top surface for bearing directly against thoraco-lumbar and lumbo-sacral vertebrae of a users spine in vectored directions in order to enhance an elliptical arch in the lower spine. A second arch projection is disposed on the bottom surface of the frame for enabling the frame and bladders to be rocked by the user in a transverse direction to a longitudinal axis of the frame.

Abstract: A connector assembly, configured to releasably couple a socket assembly, includes zero or more data conductors. An optical pathway is configured to: receive an optical signal from an optical light source positioned within the socket assembly; and provide at least a portion of the optical signal to an optical light target positioned within the socket assembly.

Abstract: Novel compounds which degrade in vivo into two or more different active antibiotics are disclosed herein. Methods, compositions, and medicaments related thereto are also disclosed.

Abstract: A system and method to monitor, detect, analyze and respond to, triggering conditions associated with packet and signal flows in a network system including attached functions and a network infrastructure. The system includes a detection function, an analysis function, and a response function. The detection function includes a monitoring sub-function, a flow definition sub-function, and a monitor counter sub-function. The flow definition sub-function defines the types of activities associated with the traffic flow that may indicate a triggering condition requiring analysis and potentially a response. The monitor sub-function observes traffic flows. The monitor counter sub-function counts the defined types of activities occurring in the device. The analysis function analyzes the event from the monitored flows, flow counters, status and other network information and determines whether a response is required.

Abstract: A compound of formula (I) wherein R1 is a C1-6 straight or branched chain alkyl group, a C2-6alkenyl group, a C2-6 alkynyl group, a C3-6cycloalkyl group or a C3-6cycloalkylC1-6alkyl group, each optionally substituted by one to three groups independently selected from: —CN; —NO2; a group —COR2 wherein R2 is hydrogen, C1-6 alkyl, —OR3 wherein R3 is hydrogen or C1-6alkyl or NR4R5 wherein R4 and R5 are independently selected from hydrogen or C1-6 alkyl; a group —S(O)mR6 wherein m is 0, 1 or 2, R6 is hydrogen, C1-6 alkyl, hydroxy or NR7R8 wherein R7 and R8 are independently hydrogen or C1-6 alkyl; a group PO(OR9)2 wherein R9 is hydrogen or C1-6 alkyl; a group NR10R11 wherein R10 and R11 are independently selected from hydrogen, C1-6 alkyl, —COR12 wherein R12 is hydrogen or C1-6 alkyl, or —S(O)m?R13 wherein m? is 0, 1 or 2 and R13 is hydrogen or C1-6 alkyl; halo; or a group —OR14 wherein R14 is hydrogen, C1-6 alkyl optionally substituted by one to three halo atoms, C6-10 aryl or —COR15 wherein R15 is hydroge